AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Brigham and Women's Hospital at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Brigham and Women's Hospital brings 5 presentations to AMP 2026 in Seattle. Its sessions centre on haematopathology, including transcriptomics in lymphomas and leukaemias and current and emerging methods for finding structural variants and gene fusions. It also covers the clinical value of detecting mismatch repair deficiency as a mutational signature in solid tumours.

OrganizationAMP 2026 Attendance
Med centres
Harvard-affiliated teaching hospital in Boston with clinical molecular pathology, haematopathology and genomic diagnostic laboratories.
Session
Thu, Nov 12
10:15am–11:45am
Talk
Thu, Nov 12
10:45am–11:15am
Clinical Utility of Detecting Mismatch Repair Deficiency as a Mutational Signature
Finding mismatch repair deficiency as a mutational signature by sequencing, set against immunohistochemistry and PCR, and what it means for patients.
Informatics · Solid Tumors
Session
Sat, Nov 14
4:15pm–5:15pm

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Brigham and Women's Hospital

Tell us what you sell and we’ll find the people at Brigham and Women's Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction